Table 3.

Comparison of acute immune thrombocytopenic purpura (ITP) treatment regimens in children.

Treatment ResponsePrednisone (4 mg/k/day 1–7, max 60 mg)IV Immunoglobulin (1–2 g/kg)Anti-D Immunoglobulin (75 μg/kg)
Response > 20,000 at 48 hours 60–70% of patients 70–80% of patients 77% of patients 
Common side effects Weight gain, irritability, hypertension, stomach pain, hyperglycemia Post-infusion headache, vomiting, allergic reactions, fever, chills Hemolysis, chills, fever, headache 
Rare but severe reactions Gastic ulcer, reflux, bleeding, hypertension-induced ICH Anaphylaxis, aseptic meningitis, renal failure Massive hemolysis with associated back pain myalgia, anemia 
Duration of intial response (days) Wide range of response after 30 days of weaning from initial dose to 0 21–72 days with platelet count greater than 20,000/mm3 21–48 days based on the75 μg/kg dose 
Treatment ResponsePrednisone (4 mg/k/day 1–7, max 60 mg)IV Immunoglobulin (1–2 g/kg)Anti-D Immunoglobulin (75 μg/kg)
Response > 20,000 at 48 hours 60–70% of patients 70–80% of patients 77% of patients 
Common side effects Weight gain, irritability, hypertension, stomach pain, hyperglycemia Post-infusion headache, vomiting, allergic reactions, fever, chills Hemolysis, chills, fever, headache 
Rare but severe reactions Gastic ulcer, reflux, bleeding, hypertension-induced ICH Anaphylaxis, aseptic meningitis, renal failure Massive hemolysis with associated back pain myalgia, anemia 
Duration of intial response (days) Wide range of response after 30 days of weaning from initial dose to 0 21–72 days with platelet count greater than 20,000/mm3 21–48 days based on the75 μg/kg dose 

or Create an Account

Close Modal
Close Modal